Definitive Contract FA865010C6105

This is a $148,828 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) to Meso Scale Diagnostics LLC, a small business provider of assay development services, laboratory testing equipment, and immunoassays. The contract, titled "TOPIC 238 AUTOMATED MULTI-ARRAY PLATFORM FOR CANCER BIOMARKERS," is for the development of an automated platform to detect cancer biomarkers. As a Phase I SBIR contract, this award is...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, a small business provider of biomedical research tools and testing equipment. The $145,089 fixed-price contract is for the development of an "Antibody Array for Early Detection of Lung Cancer." Meso Scale Diagnostics specializes in enabling biomarker detection platforms and has...

The Department of Health and Human Services National Institutes of Health National Cancer Institute (NIH NCI) awarded a Small Business Innovation Research (SBIR) Phase II contract to L2 Diagnostics LLC, a for-profit limited liability company, to develop predictive biomarkers for adverse reactions to prostate cancer radiotherapy. The $1,996,011.00 firm-fixed-price contract has a completion date of September 18, 2020 and is set aside for small businesses. L2 Diagnostics is a provider of goods...

This contract, awarded by the Air Force Research Laboratory (AFRL), is a Small Business Innovation Research (SBIR) Phase I action with a ceiling value of $74,421. The contract was awarded to Livvwisely, Inc., a small disadvantaged business, and is set aside for total small business participation. The purpose of this contract is to leverage the latest in biomarker technology to assess the true health impacts on personnel who have been exposed to environmental hazards during their service. This...

Biosensics LLC has been awarded a $325,000 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct research and development activities aligned with the agency's goals. Specifically, the contract calls for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, as outlined in NIH and CDC Solicitation A Solicitation of the National Institutes of...

Biosensics LLC, a small business, has been awarded a $2,000,000.00 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences. The contract is for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, under the Small Business Innovation Research (SBIR) program. Biosensics LLC specializes in wearable devices for monitoring physical activity, gait, balance,...

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Portable Diagnostic Systems Inc. in Robbinsville, New Jersey. The contract, with a potential value of $400,000.00, is for the development of an ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. The period of performance is September 27, 2023 to September 26, 2024, and the...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Biosono Inc., a minority-owned for-profit business. The contract is for the development of a biosensor-based core needle tumor biopsy device, under SBIR Topic 331. The fixed-price contract has a ceiling value of $224,961 and a completion date of September 11, 2015. As an SBIR Phase I contract, this represents early-stage research and development work to potentially...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI) to Meso Scale Diagnostics, LLC for the development of an antibody array to detect lung cancer. The $799,999.00 cost-plus-fixed-fee contract has a period of performance ending on July 31, 2013. Meso Scale Diagnostics, a small business, will be conducting the research and development work. The contract includes two key subcontractors, New York University School of Medicine, which...